ask="N/A"
ask_size="N/A"
average_daily_volume="79814"
bid="18.16"
bid_size="1100"
book_value="-91.82"
change="-0.07"
change_from_200_day_moving_average="3.85"
change_from_50_day_moving_average="2.61"
change_from_52_week_high="-0.27"
change_From_52_week_low="6.12"
change_in_percent="-0.38%"
close="18.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="18.40"
high_52_weeks="18.44"
last_trade_date="2/7/2017"
last_trade_price="18.17"
last_trade_size="5208"
last_trade_time="4:00pm"
low="17.54"
low_52_weeks="12.05"
market_capitalization="409.66M"
moving_average_200_day="14.32"
moving_average_50_day="15.56"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="18.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+26.90%"
percent_change_from_50_day_moving_average="+16.75%"
percent_change_from_52_week_high="-1.46%"
percent_change_from_52_week_low="+50.77%"
previous_close="18.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="71.53"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="3.28"
stock_exchange="NGM"
symbol="RARX"
volume="33361"
weeks_range_52="12.05 - 18.44"
